Neil V. Morgan mostly deals with Genetics, Mutation, FANCA, Cancer research and Endocrinology. He combines topics linked to WDR45 with his work on Genetics. His study in the field of Germline mutation and Dopamine transporter deficiency syndrome also crosses realms of Parkinsonism.
His studies deal with areas such as Complementation, FANCG and Molecular biology as well as FANCA. His Cancer research research is multidisciplinary, incorporating elements of Hypoxia-inducible factors, Renal cell carcinoma, Tumor suppressor gene, Gene product and Epigenetics. His research integrates issues of Internal medicine and Transcription factor in his study of Endocrinology.
The scientist’s investigation covers issues in Genetics, Gene, Mutation, Platelet and Cancer research. His Genetics study typically links adjacent topics like Molecular biology. Neil V. Morgan studied Mutation and Phenotype that intersect with Candidate gene and Genotype.
His Platelet research integrates issues from Megakaryocyte and Bioinformatics. His Cancer research study combines topics in areas such as Endocrinology, Hypoxia-inducible factors, Germline, Renal cell carcinoma and Tumor suppressor gene. His study focuses on the intersection of Complementation and fields such as FANCA with connections in the field of Allele.
Neil V. Morgan focuses on Platelet, Gene, Genetics, Cell biology and Exome sequencing. His work on Platelet disorder as part of general Platelet research is often related to Characterization and Workflow, thus linking different fields of science. His study brings together the fields of Thrombopoietin and Genetics.
In his study, which falls under the umbrella issue of Cell biology, Mutant, Ribosomal RNA and Missense mutation is strongly linked to Megakaryocyte. His Exome sequencing research is multidisciplinary, relying on both Genetic variants, Bioinformatics and Copy-number variation. His research in Internal medicine intersects with topics in Gastroenterology and Mutation.
His primary areas of investigation include Bioinformatics, Platelet, Exome sequencing, Phenotype and Genetics. His work deals with themes such as Comparative genomic hybridization, Exome and Recurrent miscarriage, which intersect with Bioinformatics. His Platelet study integrates concerns from other disciplines, such as Gastroenterology, Normal range, Laboratory.hematology and Mutation.
To a larger extent, Neil V. Morgan studies Gene with the aim of understanding Exome sequencing. His work in the fields of Phenotype, such as Genetic heterogeneity, overlaps with other areas such as Sitosterolemia, Eltrombopag and DIAPH1. His Genetics study is mostly concerned with Genetic variation, Thrombocytopenic purpura, Transposable element, Gene mutation and Genetic diagnosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
Richard Trembath;J R Thomson;Rajiv Machado;N Morgan.
The New England Journal of Medicine (2001)
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
Jennifer R Thomson;Rajiv D Machado;Michael W Pauciulo;Neil V Morgan.
Journal of Medical Genetics (2000)
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Rajiv D Machado;Michael W. Pauciulo;Jennifer R. Thomson;Kirk B. Lane.
American Journal of Human Genetics (2001)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota;Kevin J Turner;David R Davies;Paul G Murray.
Cancer Cell (2002)
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Neil V Morgan;Shawn K Westaway;Jenny E V Morton;Allison Gregory.
Nature Genetics (2006)
Constitutive Activation of Hypoxia-inducible Genes Related to Overexpression of Hypoxia-inducible Factor-1α in Clear Cell Renal Carcinomas
Michael S. Wiesener;Philine M. Münchenhagen;Irina Berger;Neil V. Morgan.
Cancer Research (2001)
Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome
P Gissen;P Gissen;C A Johnson;N Morgan;J M Stapelbroek.
Nature Genetics (2004)
The transmembrane protein meckelin ( MKS3 ) is mutated in Meckel-Gruber syndrome and the wpk rat
Ursula M Smith;Mark Consugar;Louise J Tee;Brandy M McKee.
Nature Genetics (2006)
Association of complementation group and mutation type with clinical outcome in Fanconi anemia
Laurence Faivre;Philippe Guardiola;Cathryn Lewis;Inderjeet Dokal.
Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E Gene.
Johan P. de Winter;Carola G.M. van Berkel;Martin A. Rooimans.
American Journal of Human Genetics (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: